Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-037712

Chief Regulatory Officer sold 5,000 shares at an average $67.01 ($335,072)

  • Chief Regulatory Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Karp Carol D. Chief Regulatory Officer 2023-08-02 Option exercise 10b5-1 +5,000 $12.15 $60,750 5,000 D: show line 1 in the form
Karp Carol D. Chief Regulatory Officer 2023-08-02 Sale 10b5-1 −4,672 $66.95 $312,784 328 D: show line 2 in the form
Karp Carol D. Chief Regulatory Officer 2023-08-02 Sale 10b5-1 −328 $67.95 $22,288 0 D: show line 3 in the form
Open-market sales · 5,000 sh · avg $67.01 · $335,072

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Karp Carol D. Chief Regulatory Officer 2023-08-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 55,000 D: show line 4 in the form
Loading xslF345X05/form4.xml…